Cost of Patients With Hemophilia A and High-Titer Inhibitors in Colombia
ConclusionsHemophilia A with high-titer inhibitors is a disease that generates significant pressure on the Colombian health system, mainly linked to the cost of factors and bypassing agents.
Source: Value in Health Regional Issues - Category: International Medicine & Public Health Source Type: research
More News: Bleeding | Children | Colombia Health | Haemophilia | Hemophilia | International Medicine & Public Health | Study